Recent advances in metabolomics of triple negative breast cancer

Recent advances in metabolomics of triple negative breast cancer

Triple‐negative Breast Cancer (TNBC) is considered as the most aggressive subtype of breast cancer. Metabolic profiling has a great significance in cancer research due to profound changes in the metabolism of cancer cells. It has been used to investigate the entire set of metabolites and changes ass...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The breast journal 2020-03, Vol.26 (3), p.498-501
Hauptverfasser: Kumari, Seema, Malla, Rama Rao
Format: Artikel
Sprache:eng
Schlagworte:
Breast cancer
cancer stem cells
Metabolism
Metabolites
Metabolomics
ROS
TNBC
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 501
container_issue 3
container_start_page 498
container_title The breast journal
container_volume 26
creator Kumari, Seema
Malla, Rama Rao
description Triple‐negative Breast Cancer (TNBC) is considered as the most aggressive subtype of breast cancer. Metabolic profiling has a great significance in cancer research due to profound changes in the metabolism of cancer cells. It has been used to investigate the entire set of metabolites and changes associated with it in disease conditions. These changes in the expression levels of metabolites bring functional changes associated with the pharmacological or nutritional intervention. The present minireview presents a brief note on changes associated with TNBC aggressiveness in terms of metabolomics.
doi_str_mv 10.1111/tbj.13524
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2286939451</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2286939451</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3884-99cad3c868566288c29de6ff5da046b96c4f0a7cbd61192d41720028299a77dd3</originalsourceid><addsrcrecordid>eNp1kMtKAzEUhoMotlYXvoAE3Ohi2iSTyWWnFq8UBKngLmSSjEyZS01mKn17U1tdCJ7Nfxbf-Tl8AJxiNMZxJl2-GOM0I3QPDHGMhHKK9-OOeJZgQt4G4CiEBUKISEQPwSDFVEhO6RBcvTjjmg5qu9KNcQGWDaxdp_O2auvSBNgWsPPlsnKwce-6K1cO5t7p0EGzOfDH4KDQVXAnuxyB17vb-fQhmT3fP06vZ4lJhaCJlEbb1AgmMsaIEIZI61hRZFYjynLJDC2Q5ia3DGNJLMWcxHcFkVJzbm06Ahfb3qVvP3oXOlWXwbiq0o1r-6AIEUymkmY4oud_0EXb-yZ-p0gqog_OJY_U5ZYyvg3Bu0ItfVlrv1YYqY1WFbWqb62RPds19nnt7C_54zECky3wWVZu_X-Tmt88bSu_AMRRf4c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2381227797</pqid></control><display><type>article</type><title>Recent advances in metabolomics of triple negative breast cancer</title><source>Wiley Online Library Journals</source><creator>Kumari, Seema ; Malla, Rama Rao</creator><creatorcontrib>Kumari, Seema ; Malla, Rama Rao</creatorcontrib><description>Triple‐negative Breast Cancer (TNBC) is considered as the most aggressive subtype of breast cancer. Metabolic profiling has a great significance in cancer research due to profound changes in the metabolism of cancer cells. It has been used to investigate the entire set of metabolites and changes associated with it in disease conditions. These changes in the expression levels of metabolites bring functional changes associated with the pharmacological or nutritional intervention. The present minireview presents a brief note on changes associated with TNBC aggressiveness in terms of metabolomics.</description><identifier>ISSN: 1075-122X</identifier><identifier>EISSN: 1524-4741</identifier><identifier>DOI: 10.1111/tbj.13524</identifier><identifier>PMID: 31489744</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Breast cancer ; cancer stem cells ; Metabolism ; Metabolites ; Metabolomics ; ROS ; TNBC</subject><ispartof>The breast journal, 2020-03, Vol.26 (3), p.498-501</ispartof><rights>2019 Wiley Periodicals, Inc.</rights><rights>Copyright © 2020 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3884-99cad3c868566288c29de6ff5da046b96c4f0a7cbd61192d41720028299a77dd3</citedby><cites>FETCH-LOGICAL-c3884-99cad3c868566288c29de6ff5da046b96c4f0a7cbd61192d41720028299a77dd3</cites><orcidid>0000-0002-0061-9327</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ftbj.13524$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ftbj.13524$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31489744$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kumari, Seema</creatorcontrib><creatorcontrib>Malla, Rama Rao</creatorcontrib><title>Recent advances in metabolomics of triple negative breast cancer</title><title>The breast journal</title><addtitle>Breast J</addtitle><description>Triple‐negative Breast Cancer (TNBC) is considered as the most aggressive subtype of breast cancer. Metabolic profiling has a great significance in cancer research due to profound changes in the metabolism of cancer cells. It has been used to investigate the entire set of metabolites and changes associated with it in disease conditions. These changes in the expression levels of metabolites bring functional changes associated with the pharmacological or nutritional intervention. The present minireview presents a brief note on changes associated with TNBC aggressiveness in terms of metabolomics.</description><subject>Breast cancer</subject><subject>cancer stem cells</subject><subject>Metabolism</subject><subject>Metabolites</subject><subject>Metabolomics</subject><subject>ROS</subject><subject>TNBC</subject><issn>1075-122X</issn><issn>1524-4741</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kMtKAzEUhoMotlYXvoAE3Ohi2iSTyWWnFq8UBKngLmSSjEyZS01mKn17U1tdCJ7Nfxbf-Tl8AJxiNMZxJl2-GOM0I3QPDHGMhHKK9-OOeJZgQt4G4CiEBUKISEQPwSDFVEhO6RBcvTjjmg5qu9KNcQGWDaxdp_O2auvSBNgWsPPlsnKwce-6K1cO5t7p0EGzOfDH4KDQVXAnuxyB17vb-fQhmT3fP06vZ4lJhaCJlEbb1AgmMsaIEIZI61hRZFYjynLJDC2Q5ia3DGNJLMWcxHcFkVJzbm06Ahfb3qVvP3oXOlWXwbiq0o1r-6AIEUymkmY4oud_0EXb-yZ-p0gqog_OJY_U5ZYyvg3Bu0ItfVlrv1YYqY1WFbWqb62RPds19nnt7C_54zECky3wWVZu_X-Tmt88bSu_AMRRf4c</recordid><startdate>202003</startdate><enddate>202003</enddate><creator>Kumari, Seema</creator><creator>Malla, Rama Rao</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0061-9327</orcidid></search><sort><creationdate>202003</creationdate><title>Recent advances in metabolomics of triple negative breast cancer</title><author>Kumari, Seema ; Malla, Rama Rao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3884-99cad3c868566288c29de6ff5da046b96c4f0a7cbd61192d41720028299a77dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Breast cancer</topic><topic>cancer stem cells</topic><topic>Metabolism</topic><topic>Metabolites</topic><topic>Metabolomics</topic><topic>ROS</topic><topic>TNBC</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kumari, Seema</creatorcontrib><creatorcontrib>Malla, Rama Rao</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The breast journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kumari, Seema</au><au>Malla, Rama Rao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent advances in metabolomics of triple negative breast cancer</atitle><jtitle>The breast journal</jtitle><addtitle>Breast J</addtitle><date>2020-03</date><risdate>2020</risdate><volume>26</volume><issue>3</issue><spage>498</spage><epage>501</epage><pages>498-501</pages><issn>1075-122X</issn><eissn>1524-4741</eissn><abstract>Triple‐negative Breast Cancer (TNBC) is considered as the most aggressive subtype of breast cancer. Metabolic profiling has a great significance in cancer research due to profound changes in the metabolism of cancer cells. It has been used to investigate the entire set of metabolites and changes associated with it in disease conditions. These changes in the expression levels of metabolites bring functional changes associated with the pharmacological or nutritional intervention. The present minireview presents a brief note on changes associated with TNBC aggressiveness in terms of metabolomics.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31489744</pmid><doi>10.1111/tbj.13524</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-0061-9327</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1075-122X
ispartof The breast journal, 2020-03, Vol.26 (3), p.498-501
issn 1075-122X
1524-4741
language eng
recordid cdi_proquest_miscellaneous_2286939451
source Wiley Online Library Journals
subjects Breast cancer
cancer stem cells
Metabolism
Metabolites
Metabolomics
ROS
TNBC
title Recent advances in metabolomics of triple negative breast cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T16%3A19%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20advances%20in%20metabolomics%20of%20triple%20negative%20breast%20cancer&rft.jtitle=The%20breast%20journal&rft.au=Kumari,%20Seema&rft.date=2020-03&rft.volume=26&rft.issue=3&rft.spage=498&rft.epage=501&rft.pages=498-501&rft.issn=1075-122X&rft.eissn=1524-4741&rft_id=info:doi/10.1111/tbj.13524&rft_dat=%3Cproquest_cross%3E2286939451%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2381227797&rft_id=info:pmid/31489744&rfr_iscdi=true